Metraipolis › archive › dc_7c3e7e87ffad

Application of Bayesian methods to accelerate rare disease drug development: scopes and hurdles — Europe PMC PMID:35526036

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/35526036
DOI
10.1186/s13023-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-10-07T17:18:00.854Z
SHA-256 of the archived text
56cc911c80ebf213fb744c12db7b1023f200f0b8441abf8cfe245b36c2522a1d
Stable URL of this page
https://metraipolis.com/documento/dc_7c3e7e87ffad

How to cite

Application of Bayesian methods to accelerate rare disease drug development: scopes and hurdles — Europe PMC PMID:35526036 — Europe PMC (en), https://europepmc.org/article/MED/35526036 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7c3e7e87ffad (Metraipolis archive dc_7c3e7e87ffad, sha256 56cc911c80ebf213fb744c12db7b1023f200f0b8441abf8cfe245b36c2522a1d)
BibTeX
@misc{dc7c3e7e87ffad,
  title = {Application of Bayesian methods to accelerate rare disease drug development: scopes and hurdles — Europe PMC PMID:35526036},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/35526036},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7c3e7e87ffad; sha256 56cc911c80ebf213fb744c12db7b1023f200f0b8441abf8cfe245b36c2522a1d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/35526036. Agents can read the archived copy with the MCP tool read_document.